Glenmark Pharma posts FY11 net at Rs 457.83 cr
Glenmark Pharmaceuticals today posted a consolidated net profit of Rs 457.83 crore for the year ended March 31, 2011.
By PTI | Updated:
NEW DELHI: Glenmark Pharmaceuticals today posted a consolidated net profit of Rs 457.83 crore for the year ended March 31, 2011.
The company's consolidated net profit for the previous fiscal stood at Rs 331.03 crore, Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company has adopted a new accounting system, consolidated figures are not comparable with those of the previous fiscal.
Total income of the company for the year ended March 31, 2011 stood at Rs 3,089.58 crore, the same was Rs 2,533.80 crore in the previous fiscal.
The company's board has recommended a dividend of Re 0.40 per share (40 per cent) of face value Re 1 on the equity share capital of the company for the financial year 2010-2011.
Shares of Glenmark Pharmaceuticals were today trading at Rs 282.20 in the afternoon trade on the BSE, down 0.79 per cent from the previous close.
The company's consolidated net profit for the previous fiscal stood at Rs 331.03 crore, Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company has adopted a new accounting system, consolidated figures are not comparable with those of the previous fiscal.
Total income of the company for the year ended March 31, 2011 stood at Rs 3,089.58 crore, the same was Rs 2,533.80 crore in the previous fiscal.
The company's board has recommended a dividend of Re 0.40 per share (40 per cent) of face value Re 1 on the equity share capital of the company for the financial year 2010-2011.
Shares of Glenmark Pharmaceuticals were today trading at Rs 282.20 in the afternoon trade on the BSE, down 0.79 per cent from the previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
